SAN DIEGO, July 22, 2016 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company committed to enabling
healthier lives through the development of innovative products and
services, today announced it will report financial results for the
second quarter 2016 after closing of the NASDAQ Global Market on
Wednesday, August 3, 2016.
A conference call hosted by Dr. Dirk van
den Boom, President and CEO, and other members of senior
management will take place on Wednesday,
August 3, at 5:00 p.m. ET
(2:00 p.m. PT) and will be webcast
live on the Sequenom Website.
Call participants should dial 877-883-0383 (U.S. / Canada) or 412-902-6506 (other countries).
Please use code 3179275. A telephonic replay will be available
through September 3, 2016 by dialing
877-344-7529 (US toll free), 855-669-9658 (Canada toll free), or 412-317-0088
(international toll), and entering the conference number
10090495.
The conference call webcast is also accessible through the
"Invest" section of the Sequenom Website at
www.sequenom.com/invest.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is
committed to enabling healthier lives through the development of
innovative products and services. The Company serves patients and
physicians by providing early patient management information.
To learn how Sequenom is interpreting the genome to improve your
life, visit www.sequenom.com.
About Sequenom Laboratories
Sequenom Laboratories, a
CAP-accredited and CLIA-certified molecular diagnostics laboratory,
has developed a broad range of laboratory tests, with a focus
principally on prenatal care. Branded under the names
HerediT®, HerediT® UNIVERSAL,
MaterniT® GENOME, MaterniT® 21 PLUS,
NextView®, SensiGene® and VisibiliT™, these
molecular genetic laboratory-developed tests provide early patient
management information for obstetricians, geneticists, and maternal
fetal medicine specialists. Sequenom Laboratories is changing the
landscape in genetic diagnostics using proprietary cutting edge
technologies. Visit www.laboratories.sequenom.com and follow
@SequenomLabs.
SEQUENOM®, HerediT®, MaterniT®
GENOME, MaterniT® 21 PLUS, NextView®,
SensiGene®, VisibiliT™ and Sequenom Laboratories™ are
trademarks of Sequenom, Inc. All other trademarks and service
marks are the property of their respective owners.
Logo - http://photos.prnewswire.com/prnh/20160225/337675LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-schedules-second-quarter-results-conference-call-for-august-3-2016-300302600.html
SOURCE Sequenom, Inc.